Supply Chain Management in the Drug Industry

Author: Hedley Rees
Publisher: John Wiley & Sons
ISBN: 0470922842
Format: PDF, Docs
Download Now
This book bridges the gap between practitioners of supply-chain management and pharmaceutical industry experts. It aims to help both these groups understand the different worlds they live in and how to jointly contribute to meaningful improvements in supply-chains within the globally important pharmaceutical sector. Scientific and technical staff must work closely with supply-chain practitioners and other relevant parties to help secure responsive, cost effective and risk mitigated supply chains to compete on a world stage. This should not wait until a drug has been registered, but should start as early as possible in the development process and before registration or clinical trials. The author suggests that CMC (chemistry manufacturing controls) drug development must reset the line of sight – from supply of drug to the clinic and gaining a registration, to the building of a patient value stream. Capable processes and suppliers, streamlined logistics, flexible plant and equipment, shorter cycle times, effective flow of information and reduced waste. All these factors can and should be addressed at the CMC development stage.

Kooperationsplattformen f r das Supply Chain Management

Author: Ronald Poppe
Publisher: Springer-Verlag
ISBN: 3658163690
Format: PDF, Mobi
Download Now
Auf der Basis von SCM-Referenzmodellen der Automobil-, Konsumgüter- und Logistikindustrie entwickelt Ronald Poppe systematisch eine SCM-Kooperationsplattform als ganzheitliches und praktisch umsetzbares Gestaltungsmodell für die kooperative Koordination der Supply Chain. Der Autor legt die Machbarkeit und den Nutzen über eine beschreibende Fallstudie der pharmazeutischen Industrie dar. Weiterhin werden die abgeleiteten Gestaltungsempfehlungen für den kombinativen Einsatz struktureller, technokratischer und informationeller Koordinationsinstrumente zusammen mit weiteren Praxisfällen konkretisiert.

Clinical Trials in Neurology

Author: Bernard Ravina
Publisher: Cambridge University Press
ISBN: 1107376572
Format: PDF, Docs
Download Now
Translating laboratory discoveries into successful therapeutics can be difficult. Clinical Trials in Neurology aims to improve the efficiency of clinical trials and the development of interventions in order to enhance the development of new treatments for neurologic diseases. It introduces the reader to the key concepts underpinning trials in the neurosciences. This volume tackles the challenges of developing therapies for neurologic disorders from measurement of agents in the nervous system to the progression of clinical signs and symptoms through illustrating specific study designs and their applications to different therapeutic areas. Clinical Trials in Neurology covers key issues in Phase I, II and III clinical trials, as well as post-marketing safety surveillance. Topics addressed include regulatory and implementation issues, outcome measures and common problems in drug development. Written by a multidisciplinary team, this comprehensive guide is essential reading for neurologists, psychiatrists, neurosurgeons, neuroscientists, statisticians and clinical researchers in the pharmaceutical industry.

Find It File It Flog It

Author: Hedley Rees
Publisher: Wordcatcher Publishing
ISBN: 1911265733
Format: PDF, Docs
Download Now
WARNING! Your life may be at risk due to the greed and avarice of pharma companies who are putting dangerous drugs on the market. Big Pharma is a money-making machine that extracts cash out of unwary investors. Producing a drug that hits the shelves involves millions of dollars of wasted money. And it's a cycle that repeats over, and over again.

The SAGE Encyclopedia of Pharmacology and Society

Author: Sarah E. Boslaugh
Publisher: SAGE Publications
ISBN: 1506301320
Format: PDF, ePub, Mobi
Download Now
The SAGE Encyclopedia of Pharmacology and Society explores the social and policy sides of the pharmaceutical industry and its pervasive influence in society. While many technical STM works explore the chemistry and biology of pharmacology and an equally large number of clinically oriented works focus on use of illegal drugs, substance abuse, and treatment, there is virtually nothing on the immensely huge business (“Big Pharma”) of creating, selling, consuming, and regulating legal drugs. With this new Encyclopedia, the topic of socioeconomic, business and consumer, and legal and ethical issues of the pharmaceutical industry in contemporary society around the world are addressed. Key Features: 800 signed articles, authored by prominent scholars, are arranged A-to-Z and published in a choice of electronic or print formats Although arranged A-to-Z, a Reader's Guide in the front matter groups articles by thematic areas Front matter also includes a Chronology highlighting significant developments in this field All articles conclude with Further Readings and Cross References to related articles Back matter includes an annotated Resource Guide to further research, a Glossary, Appendices (e.g., statistics on the amount and types of drugs prescribed, etc.), and a detailed Index The Index, Reader’s Guide, and Cross References combine for search-and-browse capabilities in the electronic edition The SAGE Encyclopedia of Pharmacology and Society is an authoritative and rigorous source addressing the pharmacology industry and how it influences society, making it a must-have reference for all academic libraries as a source for both students and researchers to utilize.

Patient Focused Network Integration in BioPharma

Author: Robert Handfield
Publisher: CRC Press
ISBN: 1482218984
Format: PDF, Mobi
Download Now
The biopharmaceutical industry as we know it today is going through a massive upheaval as a result of the uncertainty of healthcare reform and increasing regulatory pricing pressure. A wake-up call to all sectors of the healthcare value chain, Patient-Focused Network Integration in BioPharma: Strategic Imperatives for the Years Ahead explores patient-focused network integration as quite possibly the only way for organizational evolution to occur. The book discusses how to align enterprises with the patient at the center. It details the historical context of the biopharmaceutical value chain and the current set of challenges facing the industry, and then details the author’s unique and sustainable agenda for change. The book traces the critical but often ignored relationships between hospitals, insurance companies, biopharma manufacturers, government regulators, and clinical scientists. For too long, these parties have been operating in a void, without recognizing the interconnectedness of their objectives, even though these objectives are often competing and misaligned. This book points out the gaps that exist and develops a set of recommendations regarding disease treatments, clinical development of new products, and collaboration between these players that can result in a sustainable solution to the healthcare mess. Each chapter can be viewed as an independent essay, in that it deals with a specific dimension of the healthcare value chain. However, together they provide an integrated discussion on how to begin the task of creating an integrated value chain network for healthcare. The book begins with the patient, and then works its way back down the value chain, all the way to the drug development and clinical trials stage of the value chain. The common thread throughout the chapters is the emphasis on collaboration, strategic alignment, and a focus on delivering value to the end patient. Very simply, all parties in the healthcare value chain network must align their strategic planning to derive innovation solutions. It is only through true collaboration and aligned thinking that the parties in the drug development, distribution, insurance payors, and hospital provider network can deal with the incredible complexity and massive challenges that face the industry. The book provides a compelling maturity model that enables readers to gauge the level of network integration their enterprise is at today, and where they need to move in the future.

Pharma Supply Chain

Author: Christian L. J. Ewers
Publisher: Editio Cantor
ISBN: 9783871932656
Format: PDF, ePub, Docs
Download Now
"Optimization of the whole logistic network (Supply Chain) is focussed upon, from procurement via production to distribution. It has not been taken into account as yet that with an efficient Supply Chain both an optimal market supply and enormous cost savings can be achieved. Using new technologies and novel business models the authors of this book design the competitive pharmaceutical company of the future, returning to solutions already developed and proven in other branches of industry.

Der Patentauslauf von Pharmazeutika als Herausforderung beim Management des Produktlebenszyklus

Author: Christina Raasch
Publisher: Springer-Verlag
ISBN: 3835094769
Format: PDF, ePub
Download Now
Antje-Christina Raasch entwickelt ein umfassendes Ordnungsschema der durch forschende pharmazeutische Anbieter einsetzbaren Patentauslaufstrategien und analysiert diese im Detail. Anschließend leitet sie die Erfolgsfaktoren der Strategieimplementierung ab und stellt sie anhand von vier Fallstudien bedeutender Patentausläufe der letzten Jahre den Erfahrungen aus der Unternehmenspraxis gegenüber.

Logistik und Produktion

Author: Thomas Plümer
Publisher: Walter de Gruyter
ISBN: 3486700499
Format: PDF, Kindle
Download Now
Dieses Buch gibt eine systemtische Einführung in die wesentlichen Grundlagen der Logistik und Produktion. Es richtet sich an Studierende der Universitäten, Fachhochschulen, Gesamthochschulen, Berufsakademien in der Fachrichtung Wirtschaftswissenschaften sowie damit eng verwandten Fachrichtungen wie Wirtschaftsinformatik bzw. Wirtschaftsingenieurwesen. Es zeigt jedoch auch Praktikern Lösungsalternativen auf und erschließt neben der übersichtlichen Darstellung von Grundlagenwissen auch hilfreiche zusätzliche Optimierungspotenziale.